Section Arrow
BLCO.NYSE
- Bausch + Lomb Corp
Quotes are at least 15-min delayed:2026/11/05 05:45 EST
Pre Market
Last
 --
-- (--)
Bid
18.5
Ask
21.89
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 20.6
+0.57 (+2.85%)
Day High 
20.76 
Prev. Close
20.03 
1-M High
21.36 
Volume 
1.13M 
Bid
18.5
Ask
21.89
Day Low
20.3 
Open
20.5 
1-M Low
15.47 
Market Cap 
7.16B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 18.81 
20-SMA 17.73 
50-SMA 17.46 
52-W High 21.36 
52-W Low 14.44 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-0.32/1.08
Enterprise Value
12.20B
Balance Sheet
Book Value Per Share
18.01
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
5.10B
Operating Revenue Per Share
11.10
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MDLNMedline Inc40.35+6.26+18.36%42.65PE
Pre Market 40 -0.35 -0.87%
MMEDMiniMed Group, Inc.19.29+0.44+2.33%-- 
Pre Market 19.4 +0.11 +0.57%
BAXBaxter International26.5+1.01+3.96%-- 
Pre Market 26.79 +0.29 +1.09%
AVTRAvantor15.65+0.06+0.38%31.18PE
Pre Market 15.46 -0.19 -1.21%
WRBYWarby Parker21.29-0.65-2.96%365.67PE
Pre Market 21.3 +0.01 +0.05%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes brands like Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, and surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xiidra and Miebo that treat various eye complications.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.